Impact of financial support on treatment outcomes of multidrug-resistant tuberculosis: A population-based, retrospective cohort study in Shanghai, China
2024

Financial Support Improves Treatment Outcomes for Multidrug-Resistant Tuberculosis

Sample size: 865 publication 10 minutes Evidence: high

Author Information

Author(s): Chen Yong, Shen Xin, Zhang Yi, Wu Zheyuan, Xu Biao, Chen Jing, Sha Wei, Liu Xiaoxia, Ning Chenxi

Primary Institution: Shanghai Municipal Center for Disease Control and Prevention

Hypothesis

Does financial support positively influence treatment outcomes for MDR-TB patients?

Conclusion

Financial support policies for MDR-TB patients demonstrate a positive influence on treatment outcomes.

Supporting Evidence

  • 70.6% of patients achieved treatment success.
  • The median amount compensated under the subsidy policy was 2359 USD.
  • Patients benefiting from the subsidy policy had a higher rate of treatment success.
  • Financial support reduced out-of-pocket payments for patients.
  • Patients with higher reimbursement had better treatment outcomes.

Takeaway

Helping people pay for their medicine can make them get better from a serious illness called MDR-TB.

Methodology

The study used multivariate logistic regression to assess the association between financial support and treatment outcomes of MDR-TB patients.

Potential Biases

Potential biases were mitigated by the well-established MDR-TB control network in Shanghai.

Limitations

The study lacked individual and household financial situations and did not systematically collect data on the quality of patient management.

Participant Demographics

Approximately 70% of the patients were male, with a mean age of 43.7 years.

Statistical Information

P-Value

0.008

Confidence Interval

95% CI, 2.03–4.28

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.jctube.2024.100500

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication